跳至主要内容
临床试验/ACTRN12612000626864
ACTRN12612000626864已完成4 期

Does inhaled salbutamol decrease the incidence of perioperative respiratory adverse events in children at high risk for respiratory complications?

Princess Margaret Hospital for Children0 个研究点目标入组 470 人开始时间: 2012年6月12日最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
470

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
6 Years 至 16 Years(—)
性别
All

入选标准

  • Children, aged 6-16 years, male or female, undergoing elective surgery with a laryngeal mask airway. All children have to have 2 or more risk factors for respiratory complications:
  • 1)Upper respiratory tract infection < 2 weeks prior to surgery
  • 2)eczema at present or in the past
  • 3)wheezing in the last 12 months
  • 4)previous asthma (if wheezing in the past year is negative)
  • 5)dry night cough
  • 6)respiratory symptoms with exercise
  • 7)family history of asthma (mother, father and/or siblings)
  • 8)family history of eczema (mother, father and/or siblings)
  • 9)family history of hayfever(mother, father and/or siblings)
  • 10)passive smoke exposure (mother, father, caregiver)

排除标准

  • Known cardiac disease, airway or thoracic malformations, syndrome, neurological disorder, need for premedication, contraindication for LMA use as assessed by an anaesthetist independent of the study team. Any surgery involving the upper airway, chest or abdomen.

研究者

发起方
Princess Margaret Hospital for Children

相似试验